RightAnswer.com, Inc. is excited to announce the launch of the new ReproAnswer™ System, which enables healthcare providers to more effectively counsel pregnant patients about possible effects of prescription and over-the-counter medications on their developing babies. This information is critical to all women of child-bearing age – before, during, and after pregnancy and lactation.
RightAnswer developed the ReproAnswer System with SBIR (Small Business Innovation Research) grants sponsored by the Centers for Disease Control and Prevention (CDC). The CDC supports health promotion and disease prevention programs, and the SBIR grants help U.S. small businesses complete the R&D behind new products and technologies.
The ReproAnswer System bridges the gap between healthcare providers and needed information. Putting this comprehensive, curated, and targeted teratology information into the hands of healthcare providers will allow them to: